About Empyrean therapeutics

About company

Empyrean Therapeutics develops next generation cell therapies to enable global and affordable cures for diseases. The company develops unique technologies, cellular assets, and engineering processes which combine to provide a platform for rapidly manufacturing cellular drugs with novel disease fighting properties. Empyrean Therapeutics was founded in 2018 and is headquartered in Babraham, Cambridge.